The full content of Annals is available to subscribers

Subscribe/Learn More  >
Etiology |

Immunochemical, Serologic, and Immunologic Properties of Major Antigens Isolated from the Legionnaires' Disease Bacterium: Observations Bearing on the Feasibility of a Vaccine

K. H. WONG, Ph.D.; W. O. SCHALLA, M.S.; R. J. ARKO, D.V.M.; J. C. BULLARD, B.S.; and JOHN C. FEELEY, Ph.D.
[+] Article, Author, and Disclosure Information

▸Requests for reprints should be addressed to K.H. Wong, Ph.D.; Gonococcal Research Section, Bacteriology Division, Bureau of Laboratories, Center for Disease Control; Atlanta, GA 30333.

Atlanta, Georgia

Ann Intern Med. 1979;90(4):634-638. doi:10.7326/0003-4819-90-4-634
Text Size: A A A

Two antigens were isolated from each of three strains of the Legionnaires' disease (LD) bacterium. One antigen was serotype-specific; the other cross-reacted with strains of LD bacteria of different serotypes. The serotypic antigens contained all the major branched-chain fatty acids characteristic of LD bacteria and were a lipid-protein-carbohydrate complex. Electrophoresis resolved the serotypic antigen of Knoxville 1 strain into four protein bands and one glycoprotein band with molecular weights ranging from 0.5 to 7.2 x 103. The specificity of the serotypic antigens was established by immunofluorescent staining, and double gel diffusion confirmed the absence of cross-reactions between the serotypic antigens of different types and the partial identity of the serotypic antigens from serologically related strains. The cross-reacting antigens formed precipitin bands with all the homologous and heterologous sera tested. Induction of immunity by vaccination with serotypic antigens was shown in three animal models using guinea pigs and mice. Passive-transfer of immunity (IgG) was also shown in mice and guinea pigs. These observations raise the possibility of a vaccine for protection against infection of LD bacteria.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.